Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation

AIMS: The introduction of direct oral anticoagulants (DOACs) has broadened the treatment arsenal for nonvalvular atrial fibrillation, but observational studies on the benefit–risk balance of DOACs compared to vitamin K antagonists (VKAs) are needed. The aim of this study was to characterize the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Souverein, Patrick C., van den Ham, Hendrika A., Huerta, Consuelo, Merino, Elisa Martín, Montero, Dolores, León‐Muñoz, Luz M., Schmiedl, Sven, Heeke, Andreas, Rottenkolber, Marietta, Andersen, Morten, Aakjaer, Mia, De Bruin, Marie L., Klungel, Olaf H., Gardarsdottir, Helga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328267/
https://www.ncbi.nlm.nih.gov/pubmed/32627222
http://dx.doi.org/10.1111/bcp.14450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328267/
https://www.ncbi.nlm.nih.gov/pubmed/32627222
http://dx.doi.org/10.1111/bcp.14450

Ejemplares similares